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ReviewMitotic errors are common in human preimplantation embryos. The occurrence of mitotic errors is highest
during the ﬁrst three cleavages after fertilization and as a result about three quarters of human preimplanta-
tion embryos show aneuploidies and are chromosomally mosaic at day three of development. The origin of
these preimplantation mitotic aneuploidies and the molecular mechanisms involved are being discussed in
this review.
At later developmental stages the mitotic aneuploidy rate is lower. Mechanisms such as cell arrest, apoptosis,
active correction of the aneuploidies and preferential allocation of the aneuploid cells to the extra-embryonic
tissues could underlie this lower rate.
Understanding the mechanisms that cause mitotic aneuploidies in human preimplantation embryos and the
way human preimplantation embryos deal with these aneuploidies might lead to ways to limit the occur-
rence of aneuploidies, in order to ultimately increase the quality of embryos and with that the likelihood of
a successful pregnancy in IVF/ICSI. This article is part of a Special Issue entitled: Molecular Genetics of
Human Reproductive Failure.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
The introduction of human IVF into clinical practice made it possi-
ble to study human embryos in the earliest stages after conception
and it was rapidly discovered that aneuploidies, i.e. numerical chro-
mosome abnormalities, exist in human preimplantation embryos
[1–3]. In 1993, chromosomal mosaicism, the phenomenon that not
all cells in an embryo have the same chromosomal content was de-
scribed in human preimplantation embryos for the ﬁrst time [1] and
since then many studies have been published on this topic. Aneu-
ploidies have been found in embryos from women of different age,
in arrested and developing embryos, in fresh and in frozen-thawed
embryos, and in fragmented and good morphology embryos [4–11].
Mosaic embryos can consist of both diploid and aneuploid cells
(diploid-aneuploid mosaics) or of cells with multiple aneuploidies in-
volving more than one chromosome (aneuploid mosaics). The appli-
cation of high resolution DNA techniques such as array comparative
genomic hybridization (CGH) revealed that structural abnormalities,
apart from numerical abnormalities, also occur in cleavage stagelar Genetics of Human Repro-
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rights reserved.human embryos, leading to partial mosaicism of certain chromosomal
segments [12–14].
Mitotic aneuploidies have been suggested to affect the developmen-
tal potential of humanpreimplantation embryos, possibly leading to de-
velopmental arrest or embryo loss at later stages of development
[5,9,15,16]. Mitotic aneuploidies may contribute to implantation failure
or when compatible with implantation, may result in fetal or conﬁned
placental mosaicism [5]. It might also cause serious fetal complications
like intrauterine growth delay, congenital malformations, mental retar-
dation, and uniparental disomy [17].
The goal of this review is to describe the frequency of mitotic er-
rors in human preimplantation embryos and to provide insight into
the cause and the fate of these mitotic errors.2. Frequency of mitotic aneuploidies
The frequency of mitotic aneuploidies in human preimplantation
embryos can be deducted from the frequency of mosaic embryos.
However, there is considerable heterogeneity in the reported fre-
quency of mosaic embryos in the literature, with frequencies varying
from 15% to more than 90% [5,18,19]. To resolve this heterogeneity, a
systematic review and meta-analysis of studies on the chromosomal
constitution of human preimplantation embryos has recently been
performed [20]. This review shows that 73% of all human preimplan-
tation embryos after IVF are mosaic, 22% are diploid and 5% contain
other abnormalities [20]. Of the mosaic embryos, diploid-aneuploid
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aneuploid mosaic embryos (15% of all embryos).
Several factors contribute to heterogeneity in the reported fre-
quency of mosaic embryos in the literature; the deﬁnition of mosai-
cism that is used, the number of chromosomes that have been
analyzed, the type of embryos that have been studied, the develop-
mental stage at which the embryos have been analyzed and the
method of analysis that was used. One of the main reasons is the def-
inition of mosaicism that is used in a study. While some studies clas-
sify embryos as mosaic as soon as a single cell has a different
chromosomal content, others classify an embryo as diploid even
when a percentage up to 50% of aneuploid cells is present [4,21,22].
The number of chromosomes that is analyzed also plays an impor-
tant role in the varying rates of mosaicism reported [20]. Since the an-
euploidies found in human preimplantation embryos are not limited
to speciﬁc chromosomes, more mosaic embryos will be detected
when more chromosomes are tested. Most of the studies target the
sex chromosomes and the smaller autosomes as these chromosomes
are more often found in aneuploidies in prenatal samples and miscar-
riages but they might not necessarily be the most frequent in preim-
plantation embryos [7]. Several studies try to increase the number of
probes used in FISH, with 12 probes being the maximum number of
probes used in three consecutive hybridization rounds [23]. Mitotic
aneuploidies involve all chromosomes, with some chromosomes
being implicated more frequently; sex chromosomes (24.1%) and
chromosomes 8 (12.1%), 2 (8.6%), 16 (8.6%), 7 (5.2%), 13 (5.2%), 18
(5.2%), 20 (5.2%) and 21 (5.2%) [24,25]. However, these studies inves-
tigate only a few chromosomes. Some information concerning the
frequency of mitotic errors for all 24 chromosomes is available but
no extensive study comparing the frequency of mitotic errors
among all chromosomes in a substantial number of embryos has
been performed yet [12–14].
Almost all studies on the frequency ofmitotic aneuploidies use spare
embryos of compromised quality rather than embryos of good mor-
phology that are transferred or cryopreserved. In one study, a cohort
of embryos without selection, transfer or cryopreservationwas studied,
displaying a rate of diploid-aneuploid mosaic embryos not different
from the rate reported for spare embryos (53% and 59% respectively)
[20,22].
Mitotic aneuploidies have been observed at all developmental
stages of human preimplantation development, with the ﬁrst three
mitotic divisions appearing more error-prone [15,26].
Comparisons of aneuploidy rates between cleavage stage embryos
and blastocysts are conﬂicting with some studies reporting similar
rates [6], some studies reporting a lower rate in blastocysts compared
to cleavage stage embryos [5,11,27–29] and some studies reporting a
higher rate in blastocysts compared to cleavage stage embryos
[30,31]. Meta-analysis shows that mitotic aneuploidies increase from
63% at the cleavage stage to 95% at blastocyst stage [20]. Even though
the percentage of mosaic embryos increases at the blastocyst stage,
the proportion of aneuploid cells within the embryos decreases so
that blastocysts contain relatively more diploid cells (74%) compared
to cleavage stage embryos (62%) [5,10,18,20,30,32,33]. The percentage
of cells with mitotic aneuploidies decreases further in the fetus and
after birth. Mosaicism, if thoroughly analyzed, would most probably
be present in all individuals in the general population but in an insignif-
icant, low level that remains undetected and has no apparent phenotyp-
ic effect.
Mosaicism has not only been found in human embryos but also in
embryos from other species, such as cattle (22% - 42%) and
non-human primates (22% - 32.1%) [34–37]. While meiotic aneu-
ploidies are present in mouse embryos albeit at a very low rate,
data on mitotic aneuploidies in mice are lacking [38]. In order to
study the occurrence and fate of mitotic aneuploidies in mice, mitotic
errors are usually induced by for example exposure to acrylamide, a
carcinogen present in tobacco that induces chromosomal damage atﬁrst cleavage and abnormal preimplantation development, or use of
spermatozoa that had been exposed to γ-rays [39,40]. In addition,
several mice models have been developed such as the Syncp3-null
mice or the BALB/cWt mice that have an increased rate of
non-disjunction events [41,42].
2.1. Technology
The methodology used to analyze human preimplantation embryos
also contributes to the variation in the reported frequency ofmitotic an-
euploidies [20]. Some of the ﬁrst studies reporting on mitotic aneu-
ploidies in human embryos used karyotype analysis [43–45]. Although
karyotyping allows for analysis of all chromosomes, it requires dividing,
metaphase-stage cells. Only 24-36% of the embryos analyzed by
karyotyping produces metaphases of sufﬁcient quality for accurate
chromosome quantiﬁcation and in less than 25% of the embryos all
cells could be analyzed [43,45]. This technique is also biased towards
developing cells and embryos as arrested cells cannot be analyzed
since these cells do not produce metaphases. Other disadvantages of
the karyotyping technique are the difﬁculty to obtain optimal chromo-
somal banding making individual chromosomes hard to identify and
the possible loss of chromosomes during ﬁxation of the nuclei [43,45].
Karyotyping is no longer used for the analysis of chromosomal aneu-
ploidies in human preimplantation embryos.
The technique that has been usedmost often for the analysis of chro-
mosomal aneuploidies in human preimplantation embryos is ﬂuores-
cence in situ hybridization (FISH) [1,7,10,16,18,22,23,46–48]. FISH can
be applied to single cells and allows analysis of chromosome number
both in metaphase and interphase nuclei. However, the technique is
limited by the number of probes that can be used simultaneously as
only a limited number of spectrally distinct ﬂuorochromes are available
for labeling the probes. To overcome this limitation,multiple sequential
FISH rounds can be used. However, during sequential hybridization the
efﬁciency of hybridization decreases with each round so it has been
suggested to use no more than three rounds [48]. Also, FISH has an es-
timated accuracy of 92-99% per probe so there is a substantial risk of
misdiagnosiswhenmultiple probes are used [16]. It has been calculated
by amathematical model that the predictive value of FISH for an abnor-
mal test result is 90%when two chromosomes are tested but could be as
low as 41% when ﬁve chromosomes are investigated [49]. A limitation
of FISH is the necessity for ﬁxation and spreading of the nucleus of a sin-
gle cell on a microscope slide which could lead to chromosome loss or
scoring errors that arise from split signals, overlapping signals, damage
to the nucleus, loss of micronuclei, hybridization failure and probe inef-
ﬁciency [16]. In order to improve accuracy, a sequential FISH protocol
using additional probes that bind to different loci of the same chromo-
somes can be used. Subsequent hybridization rounds can also be per-
formed for any non-conclusive result and for conﬁrmation of speciﬁc
aneuploidies like monosomies [50,51]. The error rate of FISH for aneu-
ploidy screening has been described to lie between 3.7% - 17.3%
[50–52]. Moreover, FISH does not allow the detection of partial or seg-
mental aneuploidy since the FISH probes hybridize to a speciﬁc locus
or the centromere and provide information only about that segment
of the chromosome [53].
More recently, the examination of the copy number of all 24 chro-
mosomes has become possible with CGH, CGH-microarrays (aCGH)
and single-nucleotide polymorphism-based (SNP) microarrays follow-
ing whole genome ampliﬁcation (WGA) [12–14,54–57]. With CGH,
chromosome copy number analysis is achieved by co-hybridization of
differentially labeled DNA samples (a reference, most often diploid
sample and a test DNA sample of unknown chromosomal status) to
metaphase spreads derived from cells of a chromosomally diploid indi-
vidual and comparison of the relative levels of hybridization. aCGH is
based on the same principle as CGH but uses genomic clones from se-
lected regions of the genome that are spotted on a slide, instead of
metaphase cells. These techniques are applicable to cells at any phase
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have increased resolution and their analysis can be automated. Another
advantage is the possibility to detect segmental aneuploidy [53]. The
major challenge in performing genome-wide, single-cell analysis is
the possible introduction of bias as a result of failure to amplify one of
the parental alleles at randomor excess ampliﬁcation of speciﬁc regions
[54,57–59]. CGH has proven to work at least equally as well as FISH,
having further the ability to test all 24 chromosomes [53,60,61]. The re-
cent advances in the use of array technology for determining the chro-
mosomal status of a single blastomere will lead to important new
insights andwill more accurately determine the actual preimplantation
aneuploidy andmosaicism rates. However, as no test with 100% accura-
cy is yet available, one should be careful regarding the clinical use of
these tests as it could result in discarding viable embryos [61].
3. Origin of mitotic aneuploidies
3.1. Mechanisms leading to mitotic aneuploidy
Anaphase lagging in mitosis describes a delayed movement of one
chromatid during anaphase, where the chromatid fails to connect to
the spindle apparatus and is not incorporated in either nucleus of
the daughter cells. The lagging chromosome is lost, resulting in a
monosomy in one of the two daughter cells. Non-disjunction is the
failure of the sister chromatids to separate properly during mitosis,
resulting in a cell with a loss and a cell with a gain of a chromosome.
These two mechanisms are the most common mechanisms leading to
mitotic aneuploidies in human embryos [6,7,18,26,30]. Other mecha-
nisms that could cause aneuploidies are chromosome demolition,
premature cell division, errors in cytokinesis, cell fusion and chromo-
some breakage (Fig. 1). A study analyzing 299 blastocysts using FISH
for chromosomes X, Y and 18 reports that two-thirds of all complex
mosaic blastocysts are abnormal due to anaphase lagging of both an
autosome and a sex-chromosome [30]. Cells from the remainingEndoreplication
Anaphase lag
Non disjunction
Premature cell division
Normal mitosis
Fig. 1. Mechanisms leading to mitotic aneuploidy. Schematic reprblastocysts contain both non-disjunction and anaphase lagging
events with non-disjunction occurring mainly in the sex chromo-
somes and anaphase lagging in the autosomes [30]. Another study an-
alyzing 47 day 5 embryos using three rounds of FISH reports that
chromosome loss is the main mechanism leading to aneuploidy
[18]. Even though the authors conclude that the observed chromo-
some loss is probably the result of anaphase lagging the equally
high observed frequency of chromosome gains in this study could
also suggest a high rate of mitotic non-disjunction.
The observed monosomies should be interpreted with caution
when FISH is used since monosomies could be FISH artifacts either
due to overlapping signals or due to hybridization failure. Also, it
might be that non-disjunction, resulting in both losses and gains, oc-
curs in a higher rate but the cells with complementary chromosomal
content are eliminated or are not analyzable. More recently, a combi-
nation of FISH, CGH and aCGH shows no excess of chromosome losses
compared to chromosome gains [60].
Chromosome demolition, which involves the destruction and frag-
mentation of one chromosome, has been proposed as a mechanism
for chromosomal rescue of trisomic zygotes [62]. However, if chromo-
some demolition occurs in a normal diploid cell it will lead to
aneuploidy.
Premature cell divisionwithout prior duplication could result in hap-
loid cells and polyploid cells may be caused by endoreplication of the
chromosomes two or more times. Endoreplication has been observed
in human zygotes and in trophoblasts of ﬁrst trimester human placenta
[63,64]. In human embryos, tetraploidy caused by endoreplication in a
single two-cell embryo has been observed [65].
Errors in cytokinesis are also likely to contribute to mitotic aneu-
ploidy [10,66–69]. Failed or asymmetric cytokinesis results in the for-
mation of binucleated cells, tetraploidy or spindle pole abnormalities
and chromosomal chaos [70]. Analysis of the cells from cleavage stage
human embryos at the 2–4 cell stage reveals multinucleated cells in
17% of cases, the incidence of which peaked during the third cleavageDemolition
Breakage
Cell fusion
Error in cytokinesis
esentation of the mechanisms that could lead to aneuploidy.
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normally fertilized embryos increases from 5% in 2–4 cell embryos
to 10% in 9–16 cell embryos, whereas in polyspermic or parthenoge-
netic embryos the proportion is higher during early cleavage stages
but decreases at the nine- to 16-cell stage (25 and 6%, respectively),
due to arrest of these embryos [68]. Comparison of the size of the
multinucleated blastomeres to that of normal mononuclear blasto-
meres suggests that multinucleated blastomeres arise from failure
in cytokinesis. This may result from deﬁciencies in maternal mole-
cules involved in polarization, cell division and compaction or from
defects at the cell surface affecting cell-cell interactions. Cell-cell in-
teraction in cytokinesis has been shown to be important in normal
mitosis by the observation of reversible uncoupling of gap junctions
between blastomeres in mice [71]. The formation of binucleated blas-
tomeres could also arise from haploid mononucleated blastomeres
where endoreplication occurred followed by karyokinesis but not cy-
tokinesis [72].
Cell fusion of blastomeres is another possible mechanism con-
tributing to mitotic aneuploidies. Cell fusion has been demonstrated in
frozen-thawed human embryos resulting in polyploid or diploid-
polyploid mosaic embryos [73]. It is suggested that the occurrence of
blastomere fusion could be associated with changes of the cell mem-
brane, for instance ﬂuidity that might happen normally during embryo
development or might occur after freeze/thaw. Also, changes in pH,
temperature or osmotic pressure might cause blastomere fusion. How-
ever, so far cell fusion has been linked to treatment effects and there is
no evidence that it will occur spontaneously in embryos. Even if it oc-
curs spontaneously, cell fusion is a less frequently describedmechanism
compared to the other proposed mechanisms.
Another mechanism leading to aneuploidy is chromosome break-
age causing partial chromosome loss and gain [6,13,14]. The breakage
affects almost all chromosomes [6,74], with some chromosomes hav-
ing deﬁned fragile sites implicatedmore often [75]. Further, structural
aberrations are reported in embryos from women with repeated im-
plantation failure or advanced maternal age; gain/loss of entire chro-
mosome arms is most common but aberrations affecting only part of
an arm are also present [53,76–78]. Partial aneuploidy is likely to re-
sult in an unstable karyotype due to the formation of acentric and di-
centric chromosomes [78]. Despite the importance of the data
reported, these studies are limited by the resolution of the CGH
which is 40 Mb and so chromosome breakage resulting in smaller de-
letions or duplications would not have been detected. SNP array and
array CGH technologies have a higher resolution [57,79–81]. Using
such techniques, it has been shown that seventy percent of top qual-
ity embryos from young and fertile patients (couples entering the
IVF-program for sex selection) are mosaic for segmental deletions,
duplications and ampliﬁcations [12]. Based on the aneuploidy pat-
terns observed it is hypothesized that these aneuploidies occur via in-
terstitial or terminal DNA double-stranded breaks and fusions in the
zygote or during the ﬁrst two cleavages [74]. These high levels of par-
tial aneuploidy have yet to be conﬁrmed by other investigations.
3.2. Molecular mechanisms involved in aneuploidy
Preimplantation mitotic aneuploidy could be the result of several
interrelated events. The mechanisms contributing to mitotic aneu-
ploidy in human embryos will be discussed in the following sections.
3.2.1. Maternal factors leading to aneuploidy
The activation of the human genome occurs at the 4- to 8- cell stage
and many of the proteins regulating correct chromosome segregation
during the ﬁrst divisions are provided by the oocyte [82]. A defective
maternal mRNA and protein pool could lead to failure of the mecha-
nisms that guide and control cell division. Free radicals that are accumu-
lating in the oocytes throughout the years until fertilization, exposure to
external factors like radiation or chemicals, or poor vascularization ofthe antral follicle during oocyte maturationmight harm the oocyte pro-
tein pool. Examples of mechanisms that are affected by maternal pro-
teins involve microtubule kinetics, cell cycle checkpoints, DNA repair
proteins, chromosome cohesion, telomere shortening andmitochondri-
al function [83–90]. Although the overall mosaicism rate in human em-
bryos does not increase with maternal age [26,91], data suggest that
mitotic non-disjunction does [76,92,93].
In mice oocytes, the mRNA and proteins are stored in speciﬁc
compartments in the cytoplasm [94]. The transmission of mRNA and
proteins to daughter blastomeres during the ﬁrst cleavages could be
asymmetrical, resulting in differences of the maternal pool among
the blastomeres. Evidence for such asymmetrical divisions in human
embryos is lacking.
Cell divisions could also result in depletion of critical nutrients,
such as nucleoside precursors, required for chromosomal integrity
leading to chromosome fragmentation and aneuploidy [95]. For ex-
ample, folic acid deﬁciency increases chromosomal instability and an-
euploidy in human lymphocytes [96,97]; however such studies have
not been performed in human embryos.
3.2.1.1. Cell cycle checkpoints. Cell cycle checkpoints ensure correct cell
division by checking whether the processes at every cell cycle stage
have been correctly completed before progression to the next stage.
When an error occurs the checkpoint sends a signal to halt cell divi-
sion until repairs are completed, and if repair is not possible then
the checkpoint directs the cell towards apoptosis. Cell cycle check-
points function at the G1, G2 and metaphase (spindle assembly
checkpoint –SAC) stages of the cell cycle [98].
The G1 checkpoint ensures that all conditions required for DNA
synthesis are present (cell size, environment, quantity of energy,
presence of nucleotides and nutrients) and the G2 checkpoint ensures
proper duplication of the DNA during the S phase of the cell cycle and
progression to mitosis. It has been recently reported that RB, the key
protein of the G1 cell cycle checkpoint, and WEE1, the key protein of
G2 cell cycle checkpoint, are lacking from normal appearing 8-cell
stage human embryos [99]. At the same time, many genes involved
in cell division are over-expressed, suggesting that early cleavage
stage human embryos depend more on cell divisions rather than
functional checkpoints [100].
Further, the SAC protein is essential for normal mitotic progression as
it senses failure of kinetochore attachment to microtubules and halts the
cell cycle until all chromosomes are attached. Overexpression of SAC
components (BUB3, BUBR1 and MAD2) in mice embryos inhibits
metaphase-anaphase transition. Depletion of SAC accelerates
metaphase-anaphase transition during the ﬁrst cleavage leading to for-
mation ofmicronuclei, chromosomemisalignment and aneuploidy [101].
Relaxation or absence of cell cycle checkpoints during early
human preimplantation development may therefore cause aneuploi-
dy by allowing a blastomere with chromosome errors to enter and
proceed through mitosis [29,69]. Also, the presence of extra chromo-
somes in a blastomere might result in incorrect spindle formation and
erroneous chromosome-microtubule attachments leading to genome
instability during subsequent divisions.
3.2.1.2. Cohesins. Cohesins are a group of proteins regulating sister
chromatid cohesion and ensuring proper chromosome segregation.
The cohesins hold the two sister chromatids together to prevent
them from premature separation from S-phase till anaphase. Upon
entry into anaphase, the connection between the sister chromatids
is destroyed to allow their separation. Malfunction of these proteins
results in premature chromosome separation while delay in their re-
moval may result in non-disjunction.
The role of cohesins in maintaining diploidy during meiosis is well
described [102–104] but only indirect data is available on the effect of
cohesins in mitosis during human preimplantation embryo develop-
ment. Depletion of BUB 1 in mice ﬁbroblasts causes these cells to fail
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rant mitosis [105]. Further, the centromeres separate prematurely;
however, this might be due to SAC disjunction rather than a direct
role of BUB1 in protecting chromosome cohesion. BUB1 expression
has been found to be low after fertilization in human embryos up to
the 4-cell stage followed by an increase, with the greatest gene expres-
sion detected in hatched blastocysts [88]. In combination, these results
suggest that the absence of BUB1 and other proteins important for pro-
tein cohesion in the cleavage stage human embryo may be in part re-
sponsible for mitotic aneuploidy caused by premature chromosome
segregation.
3.2.1.3. Other maternal factors contributing to aneuploidy. FILIA is a pro-
tein provided by the oocyte that was found to be necessary for success-
ful early embryogenesis in mice. Depletion of FILIA from the mouse
oocyte impaired preimplantation embryo development resulting in a
high incidence of mitotic aneuploidies from abnormal spindle forma-
tion, chromosome misalignment and SAC inactivation [90]. FILIA regu-
lates the proper allocation of key spindle assembly regulators (AURKA,
PLK1 and γ-tubulin) to the microtubule-organizing centre. Further,
FILIA is required for the placement of MAD2 to kinetochores to enable
SAC function [90]. Since this gene is highly conserved in humans, ab-
sence of the FILIA protein from the maternal RNA/protein pool might
impair proper embryo development but this hypothesis needs to be
properly studied.
Another protein present in the oocyte that is required for correct
embryo development is the a-thalassemia/mental retardation
X-linked protein (ATRX). ATRX has been found in mouse oocytes to
bind to pericentric heterochromatin domains at the metaphase II
stage where it mediates chromosome alignment at the meiotic spindle.
Absence of ATRX from oocytes and 1-cell embryos exhibits chromo-
some fragments and centromeric DNA-containing micronuclei [83].
STELLA, ZAR1, MATER, PADI6 and FLOPED, maternal proteins
which are required for proper early embryo development, have
been identiﬁed in mouse embryos and most of these proteins are
also present in human embryos [85]. None of these proteins has
been studied in relation to mitotic aneuploidy in humans but they
are, together with FILIA, part of a subcortical complex in mouse em-
bryos [106]. Since FILIA has a role in maintaining diploidy in mouse
preimplantation embryos, these proteins could also have a direct or
indirect effect on euploidy.
In mouse oocytes, telomere dysfunction leads to disruption of func-
tional meiotic spindles and misalignment of chromosomes during mei-
otic division [86]. It has been demonstrated that telomere DNA length is
also associated with aneuploidy in human preimplantation embryos
[87]. Aneuploid human blastomeres display signiﬁcantly reduced telo-
mere DNA quantity relative to diploid blastomeres from sibling embry-
os, but the difference in telomere length between aneuploid and diploid
blastomeres is lost at the blastocyst stage [87].
Mitochondrial activity in developing human embryos could also cor-
relate with chromosome abnormalities [89,107]. The mitochondrial ac-
tivity of chaotic human mosaic embryos was found to be signiﬁcantly
less than that of diploid or aneuploid mosaic embryos [89]. Also, a sig-
niﬁcant difference in the mitochondrial activity was observed when
embryos that contained only diploid blastomeres were compared to
embryos that contained only aneuploid blastomeres [107].
Absence of DNA repair proteins can also cause mitotic aneuploidy.
DNA repair proteins are responsible for detecting and repairing differ-
ent DNA lesions and errors during replication. DNA repair genes are
expressed at high rates in human oocytes and blastocysts, but at
low rates after fertilization up to the 4-cell stage [84,88].
3.2.2. Paternal factors leading to aneuploidy
The centrosome, the organizing centre of the mitotic spindle, is
paternally inherited [108]. The centrosome consists of two centrioles
from which the spindle microtubules are generated. Too few or toomany centrioles may result in abnormal spindle formation and chro-
mosome malsegregation. Indeed, a higher frequency of mosaicism,
originated from an abnormal spindle organization, has been observed
in dispermic human embryos compared to monospermic or digynic
embryos [109]. Severe sperm defects may also result in a higher per-
centage of mitotic abnormalities and chaotic mosaic embryos. Embry-
os deriving from patients with nonobstructive azoospermia (NOA)
undergoing testicular sperm extraction (TESE) have an increased
rate of mosaic embryos compared embryos generated with ejaculated
sperm (53% and 26.5% respectively) [110]. The incidence of chaotic
mosaicism is also signiﬁcantly higher in embryos from NOA patients
compared to embryos from all other sperm categories conﬁrming
the hypothesis that testicular spermatozoa might have difﬁculties in
organizing the ﬁrst mitotic spindle [111].
3.2.3. Effect of in vitro procedures on the occurrence of mitotic aneuploidy
The high percentage of mitotic errors found in preimplantation
embryos could be different from the in vivo situation and it might
be induced by components of IVF/ICSI procedures. Indeed, different
mosaicism rates have been observed among embryos obtained from
different IVF centers at different chronologies and subjected to differ-
ent culture protocols [112]. Temperature ﬂuctuation, oxygen concen-
tration, culture medium and hormonal stimulation regimes could
affect spindle assembly and chromosome segregation.
Data from several studies conﬁrm that ovarian stimulation affects
embryo quality and chromosomal constitution, including postzygotic
errors [26,113]. An increase in the proportion of chromosomally ab-
normal embryos has been described with a conventional high dose
exogenous gonadotropin regimen and GnRH-agonists co-treatment
compared to a mild stimulation regimen using GnRH-antagonists
co-treatment [113]. The increase in chromosomal abnormalities ob-
served is due to an increased incidence of chromosomal mosaicism
[113]. Furthermore, a higher daily FSH dose has been linked to an in-
crease in mitotic division errors of chromosome 21 in mosaic embry-
os [26]. Chromosomal abnormalities are not solely the result of
ovarian hyperstimulation as they are also observed in embryos from
unstimulated cycles in young women (average age of 31 years-old)
[114].
Increased oxygen concentration has been shown to increase
non-disjunction events in the early divisions of non-disjunction-prone
mice embryos suggesting also that subtle changes in the IVF setting
can signiﬁcantly inﬂuence chromosome segregation [115].
Despite the possible inﬂuences of IVF procedures in the frequency
of aneuploidies, the high incidence of mosaicism found in early
human abortions [116,117] suggests that a high incidence of mosai-
cism is present in in-vivo conceptuses as well. Strikingly, the mosai-
cism rate in chorionic villus samples (CVS) in the late ﬁrst trimester
from IVF/ICSI pregnancies and spontaneous pregnancies shows no
difference in the frequency of mosaicism [24].
4. Fate of mitotic aneuploidies
In contrast with the high frequency of mitotic aneuploidies in
early preimplantation embryos, a lower percentage of blastomeres
with mitotic aneuploidies is observed in later stages of human preim-
plantation development and subsequently in established pregnancies
and live births, suggesting a natural selection against aneuploid blas-
tomeres or embryos [20].
The chromosomes involved in mitotic aneuploidies in human pre-
implantation embryos are different from those found later in embryonic
development indicating that not all types of errors have the same fate
[118,119]. It might be that errors concerning speciﬁc chromosomes
are detrimental for further embryo development causing embryos
with such errors to be absent at later stages. Some preliminary data
suggested that aneuploidy of chromosomes 1–12 is very common in
cleavage stage human embryos but in the majority of the cases these
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chromosome 13, 18, or 21 is able to persist throughout development
and is even compatible with life.
It is unclear whether there is a difference in this respect between an-
euploidies of meiotic origin and aneuploidies of mitotic origin, although
the difference in the frequency of chromosome 21 errors originating
from mitosis between early embryos and clinically recognized trisomy
21 pregnancies suggests that the majority of embryos or blastomeres
with mitotic non-disjunction involving chromosome 21 are not viable
[15].
Selection against or correction of aneuploidies is already present in
the preimplantation stage, which is demonstrated by the relatively de-
creasing number of aneuploid blastomeres from the cleavage to the
blastocyst and implantation stage [20]. Three underlying mechanisms
have been suggested: (i) cell arrest or apoptosis of aneuploid blasto-
meres and or embryos, (ii) active correction via anaphase lag,
non-disjunction or chromosomedemolition and (iii) preferential alloca-
tion of diploid/aneuploid blastomeres to embryonic or extra-embryonic
tissues (Fig. 2). These hypotheses for the fate ofmitotic aneuploidieswill
be discussed in the following paragraphs.4.1. Cell arrest
Within aneuploid embryos, arrest and apoptosis has been observed
more in embryos containing blastomeres containing the same aneu-
ploidy when compared to embryos containing both aneuploid and dip-
loid blastomeres and thesemosaic embryos reach blastocyst stagemore
easily than aneuploid embryos [29]. Cell arrest occursmore likely at the
time of compaction and cavitation [11,120–123].
This coincides with the appearance of the ﬁrst embryonic transcrip-
tion proteins. [82]. The initiation of cell arrest around the timeof embry-
onic genome activation presumably works as one of themechanisms to
prevent further development of chromosomally abnormal blastomeres.Fig. 2. Fate of mitotic aneuploidy. Schematic representation of the proposed mechanisms re
tation embryos.4.2. Apoptosis
Apoptosis, the process of programmed cell death, might also be re-
sponsible for the selection against aneuploid blastomeres. Apoptotic
nuclei, fragmented and TUNEL labeled, are signiﬁcantly increased at
morula stage and TUNEL labeled nuclei are not seen until the morula
stage, suggesting lack of apoptosis in early cleavage embryos [124].
The onset of the appearance of apoptotic markers seems to increase
closely after activation of the embryonic genome [124].
The lack of apoptosis in early cleavage stage embryos could be ei-
ther due to the ability of the embryos to suppress apoptosis or from
the absence of (components of) the apoptotic pathway. In order to
elucidate this, several studies have examined the expression of pro-
teins of the apoptotic pathways in human oocytes and embryos.
mRNA and proteins for the BAX and BCL genes that are involved in
the regulation of apoptosis are expressed from fertilization to the
blastocyst stage [125,126]. Other apoptotic markers, like PDCD5,
BAD, caspases and Harakiri are down-regulated or present in relative-
ly small amounts at cleavage stage and increase in blastocysts during
human preimplantation development [125–127]. A study in mice em-
bryos suggested that all components of the apoptotic machinery are
present even in the early 2–4 cell embryo and when these embryos
are chemically induced for apoptosis some caspase activity and DNA
fragmentation is indeed observed [128]. Induction of apoptosis after
chemical treatment in the early developmental stages has also been
observed in bovine embryos [129]. These few studies conﬁrm that
early cleavage embryos possess the complete apoptotic machinery
throughout early cleavage stage but this machinery is not active.
Apoptosis is controlled by extracellular or intracellular signals that
can both induce or suppress apoptosis. Unlike most types of mamma-
lian cells, data suggest that blastomeres do not require external sig-
nals to avoid apoptosis [130–132]. Mice embryos, from the 1-cell to
16-cell stage can survive and divide in the absence of exogenous sig-
nal even when cultured as isolated single cells [130]. Further, inApoptosis
Preferential allocation
Normal mitosis
Self correction
Cell arrest
garding the fate of aneuploid (red) and diploid (green) cells within human preimplan-
1927E. Mantikou et al. / Biochimica et Biophysica Acta 1822 (2012) 1921–1930cleavage stage human embryos there is limited cell-cell communica-
tion via gap junctions, that are necessary to propagate apoptotic sig-
nals between cells and gap junctions are expressed extensively only
after compaction [131,132]. It is still not clear though whether activa-
tion of apoptosis in later developmental preimplantation stages is a
result of the establishment of cell-cell communication, the activation
of cell cycle checkpoints that identify defective cells or other factors.
Upon activation of apoptosis, some aneuploid blastomeres among
blastocysts could undergo apoptosis leaving the blastocyst with a
higher proportion of diploid blastomeres [118]. Weaker mitotic check-
points could also initiate apoptosis of aneuploid blastomeres as shown
by deletion of genes coding for checkpoint proteins like BUB and
MAD, in mice [118,133].
According to one hypothesis, early cell death would be naturally
prevented during the early cleavage stages to maintain adequate
cell numbers that are needed in order for the embryo to proceed
through development [129]. After the onset of apoptosis, and if apo-
ptosis would result in excessive cell death then implantation failure
or embryonic loss might occur. However, there are no experimental
data to prove or disprove this hypothesis.
4.3. Self-correction
Uniparental disomy (UPD) where both copies of a certain chromo-
some in an individual originated from the same parent has been
suggested as proof for the occurrence of trisomic zygote rescue by loss
or removal of one of the three chromosomes or monosomic zygote res-
cue by replication of the missing chromosome [25,26,134,135].
The exact mechanism for such self-correction is not known but the
same mechanisms that cause mitotic errors, i.e. anaphase lagging and
non-disjunction might also be able to correct them [33,62]. Whether
the correction of the abnormal blastomeres and embryos is an active
mechanism or an accidental event needs further investigation.
4.4. Preferential allocation
Human preimplantation embryos might deal with aneuploid blas-
tomeres by preferential allocation of these blastomeres to the
trophectodermwhere chromosome aneuploidy might be better toler-
ated, and displacing diploid blastomeres to the inner cell mass or
even the embryo proper [136]. The ﬁnding of conﬁned placental mo-
saicism, i.e. the presence of aneuploid cells only in the placenta and
not in the fetus, is the primary experimental data to support such a
preferential allocation [137]. Conﬁned placental mosaicism can be di-
agnosed by ﬁnding aneuploid cells by chorionic villus sampling with-
out conﬁrmation in a follow up amniocentesis, and has been reported
in 1%–2% of all chorionic villus samples [138]. The degree of aneuploid
cells in Conﬁned placental mosaicism seems to correlate with preg-
nancy outcome like intra-uterine growth retardation [139,140]. On
the other hand, in cases of an abnormal embryo (trisomy 13 or 18),
the presence of diploid cells in the placenta could facilitate complete
embryonic and fetal development [141].
Studies in human blastocysts showed a similar degree of mosai-
cism in the inner cell mass compared to the trophectoderm or the
overall blastocyst and could thus not conﬁrm the theory of preferen-
tial allocation [27,28,31,95,121]. Preferential allocation of diploid cells
to the embryo proper has not been studied yet [27,121].
In mice, injection of only a small percentage of diploid donor ES
cells (20% diploid cells combined with 80% cells with chromosomal
abnormalities) in tetraploid blastocysts resulted in fully diploid nor-
mal adults [142]. Since tetraploid cells are excluded from the embryo
proper, offspring resulting from these injected blastocysts must have
originated from the injected ES cells, possibly indicating preferential
allocation of diploid cells to the embryo proper.
Nonetheless, it remains to be seen whether this preferential allo-
cation is indeed an active process or that for example in cases ofconﬁned placental mosaicism it was simply a matter of chance that
diploid cells could form the embryo.
4.5. Threshold for the percentage of aneuploid blastomeres
Similar to the speciﬁc chromosome involved in the aneuploidy,
the percentage of diploid blastomeres in a preimplantation embryo
could be related to the ability of that embryo to develop into a
child. The ratio of diploid blastomeres and aneuploid blastomeres
may need to be above a certain threshold for development into a nor-
mal fetus [27]. The minimum ration or number of diploid blastomeres
needed for proper development can only be speculated on, and could
be dependent on other factors such as culture environment and uter-
ine receptivity. But, limited indirect evidence supports this hypothe-
sis. Human frozen-thawed embryos that have lost nearly half of
their blastomeres due to the cryopreservation procedure are still
able to result in live births, implying that not all blastomeres of
human preimplantation embryos are necessary for proper develop-
ment into a child [21,143]. The latter can also be concluded from
the experiment mentioned above, where the injection of a small per-
centage of diploid donor ES cells in tetraploid mice blastocysts
resulted in fully diploid normal adults [142]. This experiment could
not demonstrate a correlation between chance of offspring and the
percentage of diploid cells due to its design.
5. Conclusions
This review shows that mitotic errors are common in human pre-
implantation embryos and that these errors could be caused by sever-
al interrelated mechanisms. During early human development
important mechanisms that are required for the regulation of geno-
mic integrity, like cell cycle checkpoints, cell arrest or apoptosis are
relaxed or absent leading to an increased rate of aneuploidies. Upon
embryonic genomic activation these mechanisms are re-established
and aneuploid blastomeres might be removed either by cell arrest,
apoptosis, active self-correction or allocation to the trophectoderm.
Whereas the high prevalence of mitotic errors might be an intrinsic
phenomenon of human development, aspects of the IVF/ICSI treat-
ment such as the ovarian stimulation, the use of sub-optimal sperm,
or culture conditions might also contribute to the occurrence of mi-
totic aneuploidies. A better insight in the cause and fate of aneuploidy
in human preimplantation embryos could help in limiting these pre-
implantation aneuploidies, with the ultimate goal of increasing over-
all embryo quality and with that treatment success in ART.
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